Anuh Pharma gets approval from WHO Geneva Prequalification for Pyrimcthamine API

It said API is used as anti-malarial drugs, the company said in an exchange filing.

Sep 29, 2020 04:09 IST India Infoline News Service

Shares of Anuh Pharma erased morning gains and ended lower on the stock exchanges. The company on Monday has informed the exchanges that it has received approval from the World Health Organisation - Geneva, for prequalification for Pyrimethamine API.

It said API is used as anti-malarial drugs, the company said in an exchange filing.

The stock ended at Rs189.90, down by Rs8.05 or 4.07% from its previous closing of Rs197.95 on the BSE. The scrip opened at Rs207.80 and has touched a high and low of Rs207.80 and Rs188.10 respectively. 

Related Story